MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fcimb.2024.1422500

Медицинская библиотека · Frontiers in cellular and infection microbiology · 2024

In silico testing to identify compounds that inhibit ClfA and ClfB binding to the host for the formulation of future drugs against Staphylococcus aureus colonization and infection.

Singh Shila Kumari, Bhattacharjee Minakshi, Unni Balagopalan, Kashyap Rajpal Singh, Malik Abdul, Akhtar Suhail, Fatima Sabiha

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

Staphylococcus aureus is a highly resistant pathogen. It has multiple virulence factors, which makes it one of the most pathogenic bacteria for humankind. The vast increase in antibiotic resistance in these bacteria is a warning of existing healthcare policies. Most of the available antibiotics are ineffective due to resistance; this situation requires the development of drugs that target specific proteins and are not susceptible to resistance.

METHODS

In this study, we identified a compound that acts as an antagonist of ClfA and ClfB by inhibiting their binding to host cells.

RESULTS

The shortlisted compound's binding activity was tested by docking and molecular dynamics during its interaction with proteins. The identified compound has excellent binding energy with both ClfA (-10.11 kcal/mol) and ClfB (-11.11 kcal/mol).

DISCUSSION: The molecular dynamics of the protein and compound were stable and promising for further in vitro and in vivo tests. The performance of our compound was tested and compared with that of the control molecule allantodapsone, which was reported in a previous study as a pan inhibitor of the clumping factor. An ADMET study of our selected compound revealed its reliable drug likeliness. This compound is an ideal candidate for in vitro studies.

Для цитирования: Singh Shila Kumari, Bhattacharjee Minakshi, Unni Balagopalan, Kashyap Rajpal Singh, Malik Abdul, Akhtar Suhail, Fatima Sabiha. In silico testing to identify compounds that inhibit ClfA and ClfB binding to the host for the formulation of future drugs against Staphylococcus aureus colonization and infection.. Frontiers in cellular and infection microbiology. 2024. DOI: 10.3389/fcimb.2024.1422500.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.